Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.

Primary biliary cirrhosis

Abstract

Primary biliary cirrhosis is a chronic liver disease characterised by intrahepatic bile-duct destruction, cholestasis, and, in some cases, cirrhosis. Evidence supporting the autoimmune nature of this disorder includes the appearance of highly specific antimitochondrial antibodies (AMAs) and autoreactive T cells. Concordance rates in monozygotic twins, familial prevalence, and genetic associations underscore the importance of genetic factors, whereas findings of epidemiological studies and murine models suggest a possible role for exogenous chemicals and infectious agents through molecular mimicry. The incidence of primary biliary cirrhosis has increased over recent decades, possibly attributable to augmented testing of liver biochemistry rather than a rise in disease incidence. AMAs remain the hallmark of diagnosis in most cases and allow detection of asymptomatic patients. Symptomatic individuals usually present with either pruritus or fatigue and, more rarely, with either jaundice or complications of cirrhosis. The prognosis of primary biliary cirrhosis has improved because of early diagnosis and use of ursodeoxycholic acid, the only established medical treatment for this disorder. Although not a cure, treatment can slow disease progression and delay the need for liver transplantation. However, some patients do not respond adequately to ursodeoxycholic acid and might need alternative therapeutic approaches.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(10)61965-4

Cites

143 of 143 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 143 references

Research works printed but not linked: 1

  1. Ray-Chadhuri, 2001, Epidemiology of PBC in Sheffield updated: demographics and relation to water supply, Gut, 48, 42

Cited by

See all 334

Metadata

Authors
Selmi, C., Bowlus, C. L., Gershwin, M. E., & Coppel, R. L.
Affiliations
  • University of Milan (IT)
  • University of California, Davis (US)
  • Monash University (AU)
Corresponding author
Coppel, Ross L
Venue
The Lancet
Publisher
Elsevier BV
Published
2011-05
Volume
377
Issue
9777
Pages
1600-1609
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2735553444
Cited by
334
References
143
Citations by year
2026: 10 · 2025: 13 · 2024: 18 · 2023: 25 · 2022: 22 · 2021: 18 · 2020: 21 · 2019: 27 · 2018: 30 · 2017: 27 · 2016: 17 · 2015: 29 · 2014: 28 · 2013: 20 · 2012: 19
FWCI
15.40
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK067003, R01DK090019)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
Keywords
primary biliary cirrhosis, autoimmune liver disease, antimitochondrial antibodies, intrahepatic bile duct destruction, cholestasis, genetic susceptibility, molecular mimicry, ursodeoxycholic acid, liver transplantation, disease progression, diagnosis, incidence, pruritus, fatigue
MeSH terms
Humans, Liver Cirrhosis, Biliary

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Primary biliary cirrhosis. https://app.cochat.ai/papers/10.1016/s0140-6736(10)61965-4
The paper
Selmi, C., Bowlus, C. L., Gershwin, M. E., & Coppel, R. L. (2011). Primary biliary cirrhosis. The Lancet. https://doi.org/10.1016/s0140-6736(10)61965-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.